Clinical Trial Update: Auranofin for Giardia Protozoa [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating auranofin for Giardia and amoebic dysentery has completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Amoebic Dysentery
• Giardiasis

Drugs mentioned

• Auranofin (auranofin)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Amoebic Dysentery, Giardiasis | Phase 2 | Status: COMPLETED | Results posted: 2023-01-26